Angus Chen from STAT News - Journalist Profile

	Profile	Recent Articles on Subject
1	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	The most essential and memorable JPM moments, recapped - 5 days ago
2	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	The most essential and memorable JPM moments, recapped - 5 days ago Beneath deal-making at J.P. Morgan conference, debate and sympathy over Americans’ anger at health care - 5 days ago STAT+: Johnson & Johnson says its lung cancer drug significantly extended survival - 15 days ago Why bone marrow transplants are becoming less common - 29 days ago STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - about 1 month ago Biopharma leaders lay out vision for the future of blood cancer treatment - about 1 month ago Using AI, images are fueling a new boom in cell biology - 3 months ago STAT+: Q&A: AI is coming for lots of jobs. What about that of the cancer researcher? - 4 months ago Blood cell counts have unfairly kept Black and Middle Eastern people from clinical trials, study says - 4 months ago Study exposes the dangerous ‘hidden’ mental burden of cancer on patients’ spouses - 5 months ago Bone marrow donors needn’t be perfect match, study says, paving way for more equitable access - 6 months ago CAR-T cell therapy’s complications, as well as its benefits, become clearer in ‘flurry’ of cancer studies - 6 months ago STAT+: ASCO preview: a promising solid tumor CAR-T, an AI patient navigator, and improving palliative care - 8 months ago STAT+: FDA advisers endorse Guardant Health’s colon cancer screening test - 8 months ago STAT+: When a cancer drug fails, oncologists often fly blind. A precision technique might light the way - 10 months ago STAT+: New liquid biopsy screening test for pancreatic cancer shows promise in early data - 10 months ago STAT+: Leading MD Anderson oncologist disputes junior scientist’s claims in lawsuit over research credit - 11 months ago STAT+: In ‘major milestone,’ FDA approves first cell therapy for solid tumors - 11 months ago STAT+: A flurry of research misconduct cases has universities scrambling to protect themselves - 11 months ago STAT+: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit - 12 months ago Quitting alcohol — or even drinking less — reduces risk of oral cavity and esophageal cancer, per new analysis - about 1 year ago STAT+: FDA alters warning label for Carvykti CAR-T, although link to secondary cancers is unclear - about 1 year ago STAT+: A targeted therapy shows it can offer a ‘last, great chance’ for some acute leukemia patients - about 1 year ago STAT+: CAR-T, recently used in a lupus patient, helps other autoimmune patients, too, in small study - about 1 year ago STAT+: Was CAR-T therapy a bystander or driver of lymphoma? Researchers examine first published case - about 1 year ago STAT+: Blood cancers may arise from CAR-T cells, but experts think only in very rare cases - about 1 year ago STAT+: Colon cancer prevention paradox: Higher-risk patients pay more for colonoscopy - about 1 year ago STAT+: FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma - about 1 year ago Why do some CAR-T cancer patients have severe complications? Data points to latent virus - about 1 year ago American Cancer Society expands lung cancer screening guidelines for cigarette smokers - about 1 year ago Cancer disparities persisted even among clinical trial participants, study finds - about 1 year ago STAT+: Long underappreciated, gamma-delta T cells may be key to colon cancer defense, study says - over 1 year ago STAT+: Cancer drug shortages widen disparities between big systems and small - over 1 year ago
3	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	The most essential and memorable JPM moments, recapped - 5 days ago STAT+: FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma - about 1 year ago
4	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	Biopharma leaders lay out vision for the future of blood cancer treatment - about 1 month ago STAT+: FDA advisers endorse Guardant Health’s colon cancer screening test - 8 months ago STAT+: A flurry of research misconduct cases has universities scrambling to protect themselves - 11 months ago STAT+: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit - 12 months ago
5	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Biopharma leaders lay out vision for the future of blood cancer treatment - about 1 month ago
6	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	Biopharma leaders lay out vision for the future of blood cancer treatment - about 1 month ago
7	Alia Sajani STAT News	CAR-T cell therapy’s complications, as well as its benefits, become clearer in ‘flurry’ of cancer studies - 6 months ago
8	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma - about 1 year ago